249 related articles for article (PubMed ID: 15850791)
1. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.
Gilbert L; Toivola J; White D; Ihalainen T; Smith W; Lindholm L; Vuento M; Oker-Blom C
Biochem Biophys Res Commun; 2005 Jun; 331(2):527-35. PubMed ID: 15850791
[TBL] [Abstract][Full Text] [Related]
2. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
Michel PO; Mäkelä AR; Korhonen E; Toivola J; Hedman L; Söderlund-Venermo M; Hedman K; Oker-Blom C
J Virol Methods; 2008 Sep; 152(1-2):1-5. PubMed ID: 18598721
[TBL] [Abstract][Full Text] [Related]
3. Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells.
Gilbert L; Toivola J; Lehtomäki E; Donaldson L; Käpylä P; Vuento M; Oker-Blom C
Biochem Biophys Res Commun; 2004 Jan; 313(4):878-87. PubMed ID: 14706624
[TBL] [Abstract][Full Text] [Related]
4. Disassembly of structurally modified viral nanoparticles: characterization by fluorescence correlation spectroscopy.
Toivola J; Gilbert L; Michel P; White D; Vuento M; Oker-Blom C
C R Biol; 2005 Dec; 328(12):1052-6. PubMed ID: 16314283
[TBL] [Abstract][Full Text] [Related]
5. [Preparation of human parvovirus B19 virus-like particles].
Zou X; Dong L; Song J; Qu J; Yu X; Lu Z; Hong T
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):575-9. PubMed ID: 19637634
[TBL] [Abstract][Full Text] [Related]
6. Visualization of the externalized VP2 N termini of infectious human parvovirus B19.
Kaufmann B; Chipman PR; Kostyuchenko VA; Modrow S; Rossmann MG
J Virol; 2008 Aug; 82(15):7306-12. PubMed ID: 18508892
[TBL] [Abstract][Full Text] [Related]
7. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
[TBL] [Abstract][Full Text] [Related]
9. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
[TBL] [Abstract][Full Text] [Related]
10. Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles.
Gilbert L; Toivola J; Välilehto O; Saloniemi T; Cunningham C; White D; Mäkelä AR; Korhonen E; Vuento M; Oker-Blom C
J Nanobiotechnology; 2006 Dec; 4():13. PubMed ID: 17156442
[TBL] [Abstract][Full Text] [Related]
11. Construction of protein-functionalized virus-like particles of parvovirus B19.
Bustos-Jaimes I; Soto-Román RA; Gutiérrez-Landa IA; Valadez-García J; Segovia-Trinidad CL
J Biotechnol; 2017 Dec; 263():55-63. PubMed ID: 28935566
[TBL] [Abstract][Full Text] [Related]
12. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
Franssila R; Hedman K
Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862
[TBL] [Abstract][Full Text] [Related]
13. Monitoring human parvovirus B19 virus-like particles and antibody complexes in solution by fluorescence correlation spectroscopy.
Toivola J; Michel PO; Gilbert L; Lahtinen T; Marjomäki V; Hedman K; Vuento M; Oker-Blom C
Biol Chem; 2004 Jan; 385(1):87-93. PubMed ID: 14977050
[TBL] [Abstract][Full Text] [Related]
14. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
Ekman A; Hokynar K; Kakkola L; Kantola K; Hedman L; Bondén H; Gessner M; Aberham C; Norja P; Miettinen S; Hedman K; Söderlund-Venermo M
J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
[TBL] [Abstract][Full Text] [Related]
15. Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3.
Inoue T; Kawano MA; Takahashi RU; Tsukamoto H; Enomoto T; Imai T; Kataoka K; Handa H
J Biotechnol; 2008 Mar; 134(1-2):181-92. PubMed ID: 18243389
[TBL] [Abstract][Full Text] [Related]
16. Green fluorescent protein - Tagged HCV non-enveloped capsid like particles: development of a new tool for tracking HCV core uptake.
Katsarou K; Serti E; Tsitoura P; Lavdas AA; Varaklioti A; Pickl-Herk AM; Blaas D; Oz-Arslan D; Zhu R; Hinterdorfer P; Mavromara P; Georgopoulou U
Biochimie; 2009 Jul; 91(7):903-15. PubMed ID: 19401214
[TBL] [Abstract][Full Text] [Related]
17. Peptide display on a surface loop of human parvovirus B19 VP2: Assembly and characterization of virus-like particles.
Santillán-Uribe JS; Valadez-García J; Morán-García Adel C; Santillán-Uribe HC; Bustos-Jaimes I
Virus Res; 2015 Apr; 201():1-7. PubMed ID: 25701743
[TBL] [Abstract][Full Text] [Related]
18. In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.
Sánchez-Rodríguez SP; Enrriquez-Avila JV; Soto-Fajardo JM; Peña-Montes C; Bustos-Jaimes I
Mol Biotechnol; 2015 Apr; 57(4):309-17. PubMed ID: 25389040
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
20. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
Kawase M; Momoeda M; Young NS; Kajigaya S
Virology; 1995 Aug; 211(2):359-66. PubMed ID: 7544049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
